Basal Cell Carcinoma Treatment Market
According to Intent Market Research, the Basal Cell Carcinoma Treatment Market is expected to grow from USD 6.3 billion in 2023 at a CAGR of 10.4% to touch USD 12.5 billion by 2030. The Basal Cell Carcinoma Treatment Market is dominated by key players such as, Merck & Co., Inc., Bristol-Myers Squibb Company, Roche Holding AG, Pfizer Inc., and Amgen Inc..